Table 2.
Correlation between the expression of LINC01419 and the clinicopathological characteristics of HCC patients.
| Clinicopathologic characteristics | n | LINC01419 | p value | |
|---|---|---|---|---|
| High expression | Low expression | |||
| Age (year) | 0.923 | |||
| ≤60 | 16 | 6 | 10 | |
| >60 | 25 | 9 | 16 | |
| Gender | 0.975 | |||
| Male | 19 | 7 | 12 | |
| Female | 22 | 8 | 14 | |
| Viral status | 0.273 | |||
| Positive | 35 | 14 | 21 | |
| Negative | 6 | 1 | 5 | |
| Serum AFP (ng/mL) | 0.460 | |||
| ≤20 | 6 | 3 | 3 | |
| >20 | 35 | 12 | 23 | |
| Liver cirrhosis | 0.613 | |||
| Yes | 37 | 14 | 23 | |
| No | 4 | 1 | 3 | |
| Tumor size (cm) | 0.020 | |||
| ≤5 cm | 18 | 3 | 15 | |
| >5 cm | 23 | 12 | 11 | |
| Thrombus | 0.001 | |||
| Positive | 12 | 9 | 3 | |
| Negative | 29 | 6 | 23 | |
| Micro vascular invasion (MVI) | 0.024 | |||
| Yes | 13 | 8 | 5 | |
| No | 28 | 7 | 21 | |
| TNM stage | 0.013 | |||
| I-II | 24 | 5 | 19 | |
| III-IV | 17 | 10 | 7 | |
| Tumor differentiation | 0.026 | |||
| Well | 8 | 1 | 7 | |
| Moderate | 25 | 8 | 17 | |
| Poor | 8 | 6 | 2 | |
| Lymph nodes metastasis | 0.024 | |||
| Yes | 13 | 8 | 5 | |
| No | 28 | 7 | 21 | |
| Recurrence | 0.608 | |||
| Yes | 17 | 7 | 10 | |
| No | 24 | 8 | 16 | |